
Our client, an Illinois pharmacy, was targeted by a major PBM with cease-and-desist notices that alleged violations of the Provider Manual. Although the pharmacy responded to the PBM in an attempt to address the allegations, the PBM terminated the pharmacy anyway. At that point, the pharmacy retained our firm, and we immediately sprung into action to reverse the impending termination on short notice.
Successful PBM Appeals Often Require Legal Advocacy
Throughout the appeal process, HLA's experienced healthcare defense attorneys meticulously presented documentation and legal analysis that systematically addressed the PBM's alleged violations and demonstrated that either no violation occurred, or that any violation was an isolated error that did not support termination. Specifically, we combine our arguments on the facts with extensive legal research and analysis demonstrating why the PBM is not entitled to terminate the agreement at issue under relevant federal, state, and common law.
HLA's Legal Methods are Tailored to Each Case
Our method for approaching these cases is to present the client's narrative and facts in a convincing and compelling fashion, relying on our subject matter expertise, to explain why vague statements in a manual do not prohibit or apply to the facts at issue. In addition, it is important to address the PBM's concern that the conduct at issue not recur. Accordingly, because our firm employs the former Chief Compliance Officer of United Health Group, we are in a position to recommend tailored compliance strategies that the PBMs will accept in mitigation.
As part of our work in this case, our healthcare compliance specialists implemented new standard operating procedures, updated policies, and retrained staff, convincing the PBM to reinstate the pharmacy based on improved compliance protocols. This often tips the balance towards reinstatement.
Network Termination Can be Avoided
We work on many network appeals, so we can be efficient in budgeting to achieve desirable results. In this case, the pharmacy was about to be sold to a new owner, and the network termination obviously destroyed a lot of that value. By winning network reinstatement on appeal, we were able to dramatically increase the owner's return on investment. Nonetheless, if you are at risk of termination, the earlier you involve qualified counsel, the better. We are always available to help.
MORE ARTICLES BY CATEGORY
The 2025 Healthcare Fraud Takedown Is a Warning Shot for Wound Care Providers
Wound care is now an enforcement priority. The 2025 fraud takedown targets skin substitute billing, graft utilization, and Medicare compliance.
Read More >>FDA and Novo’s Uncharted Waters to Exert Pressure on Hims & Hers and GLP-1 Compounders
Novo’s lawsuit against Hims & Hers, coupled with FDA’s referral to the DOJ, marks a direct escalation against 503A compounded semaglutide. If your pharmacy dispenses, compounds, or markets GLP-1 therapies, this is not a headline, it is a regulatory turning point.
Read More >>What Wells Pharma v. Zyla Life Sciences Means for Compounding Pharmacies and Outsourcing Facilities
A pending Supreme Court case could reshape how compounding pharmacies face litigation under state unfair competition laws tied to FDA approval standards.
Read More >>Health Law Alliance Welcomes Compounding Expert Pharmacist-Attorney Dr. Martha Rumore as Of Counsel
Health Law Alliance adds powerhouse Pharmacist/Attorney Dr. Martha Rumore to their team of boutique healthcare attorneys.
Read More >>







